Finally, we show that application of the CP model to primary patient-derived datasets can provide quantitative insights and predictions that may be useful in guiding further research and biomedical interventions, such as the disruption of keratinocyte differentiation in EEC syndrome patients (Fig. 4). The gene discussed is CP; the disease is EEC syndrome.